Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection
Clinical trial NCT02384395 · COMPLETED
Trial details
- NCT number
- NCT02384395
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2020-03-06
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.